The role of estrogens at men. Part 2. Private clinical endocrinology and pathophysiology of estrogens at men

The role of estrogens at men. Part 2. Private clinical endocrinology and pathophysiology of estrogens at men

Show other versions (1)

Bibliographic Details
Main Authors:	I. A. Tyuzikov, S. Yu. Kalinchenko, L. O. Vorslov, Yu. A. Tishova
Format:	Article
Language:	Russian
Published:	ABV-press 2015-04-01
Series:	Андрология и генитальная хирургия
Subjects:	estrogens testosterone interaction man endocrinology physiology pathophysiology central nervous system reproductive system sexual system gynecomastia bone system cardiovascular system benign prostatic hyperplasia prostate cancer
Online Access:	https://agx.abvpress.ru/jour/article/view/127

Similar Items

The role of estrogens at men. Part 2. Private clinical endocrinology and pathophysiology of estrogens at men
by: I. A. Tyuzikov, et al.
Published: (2015-04-01)

The role of estrogens at men. Part 1. General and developmental endocrinology, physiology and pathophysiology of estrogens at men
by: I. A. Tyuzikov, et al.
Published: (2015-02-01)

The role of estrogens at men. Part 1. General and developmental endocrinology, physiology and pathophysiology of estrogens at men
by: I. A. Tyuzikov, et al.
Published: (2015-02-01)

Vitamin D, men’s health and prostate (literature review)
by: I. A. Tyuzikov, et al.
Published: (2014-12-01)

Vitamin D, men’s health and prostate (literature review)
by: I. A. Tyuzikov, et al.
Published: (2014-12-01)

Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
by: Da Silva MHA, et al.
Published: (2019-01-01)

The concentration of androgens and estrogens in benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2021-02-01)

Efficacy of Phlogenzyme® in men following transurethral laser enucleation of prostate hyperplasia: results of a randomized trial
by: S. V. Kotov, et al.
Published: (2024-04-01)

Bulk mRNA-sequencing data of the estrogen and androgen responses in the human prostate cancer cell line VCaPGEO)
by: Camille Lafront, et al.
Published: (2024-12-01)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2021-07-01)

Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia
by: Goto Gangkak, et al.
Published: (2017-03-01)

Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia
by: Lingmin Song, et al.
Published: (2016-07-01)

Exploring the Role of Testosterone Replacement Therapy in Benign Prostatic Hyperplasia and Prostate Cancer: A Review of Safety
by: André Rizzuti, et al.
Published: (2022-02-01)

Bulk mRNA-seq data from wild-type and prostate cancer-developing mice reveal a reprogramming of the estrogen and androgen responses after carcinogenesis
by: Camille Lafront, et al.
Published: (2024-12-01)

Histopathological Study of Prostatic Biopsies in Men with Prostatism
by: Kusuma Puttaswamy, et al.
Published: (2016-02-01)

Upregulation of Oxytocin Receptor in the Hyperplastic Prostate
by: Zhuo Li, et al.
Published: (2018-08-01)

The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective
by: Teow J. Phua
Published: (2021-06-01)

Recent advances in managing chronic prostatitis/chronic pelvic pain syndrome [version 1; referees: 2 approved]
by: Jaspreet Sandhu, et al.
Published: (2017-09-01)

Tumor necrosis factor alpha as a potential marker for prostate cancer
by: M. S. Ali, et al.
Published: (2020-12-01)

Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
by: Giovanni Corona, et al.
Published: (2014-10-01)

Epidemiology of senile prostatic enlargement among elderly men in Arar, Kingdom of Saudi Arabia
by: Abdullah Barghash Alanazi, et al.
Published: (2017-09-01)

Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
by: Faruk Kucukdurmaz, et al.
Published: (2017-12-01)

Treatment outcomes of benign prostate hyperplasia by thulium vapoenucleation of the prostate in aging men
by: Chun-Ming Hou, et al.
Published: (2016-12-01)

Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
by: Kang Hee Shim, et al.
Published: (2018-01-01)

Cordycepin Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats via Modulation of AMPK and AKT Activation
by: Abdulmohsin J. Alamoudi, et al.
Published: (2022-08-01)

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia
by: Hagberg KW, et al.
Published: (2017-02-01)

Comparison of the pre-treatment testosterone levels in benign prostatic hyperplasia and prostate cancer patients
by: D.E. Orakwe, et al.
Published: (2017-06-01)

Prostatic artery embolization in men with severe hemophilia a: a case report of two patients
by: Petra Svarc, et al.
Published: (2022-04-01)

Correlation between the number of breast duct cells expressing androgen, estrogen and progesterone receptors and the size of the changed tissue in patients with gynecomastia
by: Mladenović Danilo, et al.
Published: (2023-01-01)

Effect of a Combination of Dutasteride and Parenteral Testosterone Undecanoate on Testosterone Deficiency Symptoms and Prostate in Patients with Testosterone Efficiency and Benign Prostatic Hyperplasia
by: Min Gu Park, et al.
Published: (2020-06-01)

The prostate : everything you need to know /
by: Taguchi, Yosh, 1933-, et al.
Published: (2001)

Efficacy of different modes of pharmacotherapy for men with lower urinary tract symptoms benign prostatic hyperplasia depending of androgenic status
by: O. I. Bratchikov, et al.
Published: (2017-02-01)

Zinc Deficiency in Men Over 50 and Its Implications in Prostate Disorders
by: Ann Katrin Sauer, et al.
Published: (2020-08-01)

Evaluation of serum prostatic-specific antigen levels in diabetic and non-diabetic men diagnosed with benign prostatic hyperplasia
by: Udoh EA, et al.
Published: (2022-01-01)

A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection
by: Yu Wu, et al.
Published: (2017-01-01)

Association of receptor expression with prostate volume in benign prostatic hyperplasia
by: Karli Sreenivasulu, et al.
Published: (2019-01-01)

Citrus reticulata fruit peel extract ameliorates testesterone-induced benign prostatic hyperplasia-like phenotypes in rats
by: Alex Boye, et al.
Published: (2024-05-01)

The Difference of Lower Urinary Tract Symptoms Between Sympathetic Hyperactive and Hypoactive Men
by: Dong Geun Oh, et al.
Published: (2013-03-01)

Changes in specific serum biomarkers during the induction of prostatic hyperplasia in dogs
by: Kamran Golchin-Rad, et al.
Published: (2019-12-01)

Short-term effect of tamsulosin and finasteride monotherapy and their combination on nigerian men with benign prostatic hyperplasia
by: Benjamin O Odusanya, et al.
Published: (2017-01-01)